Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indivior Pharmaceuticals Inc. Common Stock (INDV) vs Ferrari NV (RACE) Price & Performance

Indivior Pharmaceuticals Inc. Common StockTrade
Ferrari NVTrade

Price performance (Past 24H)

Key statistics

Indivior Pharmaceuticals Inc. Common Stock vs Ferrari NV — how do they compare? Indivior Pharmaceuticals Inc. Common Stock trades at $34.01 (market cap $4.18B), while Ferrari NV trades at $382.14 (market cap $68.73B). The key difference: Ferrari NV is far larger — about 16.4× Indivior Pharmaceuticals Inc. Common Stock's market cap, and Ferrari NV pays a 1.08% dividend while Indivior Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Indivior Pharmaceuticals Inc. Common Stock for 0 Days and Ferrari NV for 126 Days on average.

INDVRACE
Market Cap
$4.18B$68.73B
Volume
1,819,746283,474
Sector
HealthConsumer Cyclical
52-Week High
$41.83$436.54
52-Week Low
$24.09$314.63
Typical Hold Time
0 Days126 Days
Enterprise Value
$4.47B$70.60B
Dividend Yield
—1.08%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Indivior Pharmaceuticals Inc. Common Stock

No Aura AI signal available yet.

Ferrari NV

Ferrari (RACE) trades at $387.35, down 0.49% on the day, amid a bearish technical signal. The company demonstrates strong fundamentals with revenue growth from $7.15B in 2025 to a projected $7.4B in 2026 and a net income margin of 22.25%. Recent earnings beats and a share buyback program highlight operational strength. Analyst consensus is bullish with a $462.75 price target, though technical indicators show near-term pressure with support at $384.

The outlook remains positive given Ferrari's premium brand and consistent profitability, but high valuation multiples (P/E 37.67) and economic sensitivity pose risks. Institutional buying and bullish analyst ratings support upside potential, yet investors should monitor competitive pressures and macroeconomic headwinds that could impact luxury demand.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

INDV
100% Buy0% Sell
Avg holding period · 0 Days
RACE
21% Buy79% Sell
Avg holding period · 126 Days

Top news

Latest headlines on both assets

About Indivior Pharmaceuticals Inc. Common Stock

Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.

Read more on INDV →

About Ferrari NV

Ferrari engineers and manufactures some of the world's most expensive exotic sports cars. The Ferrari brand is synonymous with Formula One racing, exclusivity, Italian design, and state-of-the-art technology. Ferrari also has a captive finance company that provides funding for dealers and clients.

Read more on RACE →